What is the global market size of Cardiovascular Devices Market?

Global Cardiovascular Devices Market size was valued at USD 17.822 billion in 2021 and is poised to grow from USD 18.8 billion in 2022 to USD 31.1 billion by 2030, growing at a CAGR of 5.5% in the forecast period (2023-2030).

Who are the key vendors in the Global Cardiovascular Devices Market?

The cardiovascular devices market is relatively fragmented, with a high level of competition. Companies are working on new product launches and other initiatives to provide better equipment to their customers and expand their companies globally. These industry leaders are expanding their client base in a variety of ways, and many organizations are forming strategic and creative partnerships with other start-up businesses to increase market share and profitability. 'Abbott Laboratories', 'Boston Scientific Corporation', 'Medtronic, Inc.', 'St. Jude Medical, Inc.', 'Johnson & Johnson', 'Terumo Corporation', 'Edwards Lifesciences Corporation', 'Biotronik SE & Co. KG', 'LivaNova PLC', 'Getinge AB', 'Hill-Rom Holdings, Inc.', 'Koninklijke Philips N.V.', 'Siemens Healthineers AG', 'GE Healthcare', 'Toshiba Corporation', 'Fujifilm Holdings Corporation', 'Hitachi, Ltd.', 'Nihon Kohden Corporation', 'Cardiac Science Corporation', 'Schiller AG'.

What is the key driver of Global Cardiovascular Devices Market?

Rise in the Prevalence of Cardiovascular Diseases to Boost the Global Market

What is the key market trend for Global Cardiovascular Devices Market?

High Demand for Advanced Features in Cardiovascular Devices

Which region accounted for the largest share in Global Cardiovascular Devices Market?

On the basis of region, the global cardiovascular devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Cardiovascular Devices Companies

Cardiovascular Devices Market Competitive Landscape

Top Players in the Global Cardiovascular Devices Market

Abbott Laboratories
Boston Scientific Corporation
Medtronic, Inc.
Johnson & Johnson
Terumo Corporation
Edwards Lifesciences Corporation
Biotronik SE & Co. KG
LivaNova PLC
Getinge AB
Baxter International Inc. (Hill-Rom Holdings, Inc.)
Koninklijke Philips N.V.
Siemens Healthineers AG
GE Healthcare
Toshiba Corporation
Fujifilm Holdings Corporation
Hitachi, Ltd.
Nihon Kohden Corporation
Collateral Medical Pvt. Ltd.
Schiller AG
B. Braun Melsungen AG

Cardiovascular Devices Market

FAQs

Global Cardiovascular Devices Market size was valued at USD 44.9 billion in 2022 and is poised to grow from USD 49.1 billion in 2023 to USD 94.9 billion by 2031, growing at a CAGR of 8.5% during the forecast period (2024-2031).

The cardiovascular devices market is competitive, dominated by established medical technology companies and driven by continuous innovation, a collaborative approach and a focus on expanding global reach. These agencies have constructed a vast market percentage via complicated cardiovascular solutions, from implantable devices together with pacemakers and stents to advanced imaging systems. Key players use partnerships and acquisitions to gain competitive benefit and drive growth. 'Abbott Laboratories ', 'Boston Scientific Corporation ', 'Medtronic, Inc. ', 'Johnson & Johnson ', 'Terumo Corporation ', 'Edwards Lifesciences Corporation ', 'Biotronik SE & Co. KG ', 'LivaNova PLC ', 'Getinge AB ', 'Baxter International Inc. (Hill-Rom Holdings, Inc.) ', 'Koninklijke Philips N.V. ', 'Siemens Healthineers AG ', 'GE Healthcare ', 'Toshiba Corporation ', 'Fujifilm Holdings Corporation ', 'Hitachi, Ltd. ', 'Nihon Kohden Corporation ', 'Collateral Medical Pvt. Ltd. ', 'Schiller AG ', 'B. Braun Melsungen AG '

Worldwide, cardiovascular diseases (CVDs) are the leading cause of death, driving the demand for advanced medical devices. Sedentary lifestyles, poor dietary intake, and an aging population increase the risk of cardiovascular conditions such as congestive heart failure, heart failure and hypertension. Consequently, life-saving devices such as pacemakers, defibrillators and stents are increasingly needed in developed and developing areas as health systems prioritize preventive care with early detection of disease. Hospitals and clinics following the pace of using cutting-edge technology to improve patient outcomes, government programs and nonprofits are launching programs to raise awareness of high-risk populations have been monitored.

Expanding Home Health Solutions: Trends in home healthcare and self-management are changing the cardiovascular devices market. Wearable ECG devices, blood pressure monitors, and remote patient monitoring methods provide real-time data, allowing individuals to manage chronic heart failure without repeated hospital visits. This trend is not to make patients not only easier, reducing the healthcare costs but supporting the transition to preventative healthcare.

As per cardiovascular devices market outlook, North America dominated the market and accounted for the largest revenue share at 47.7% in 2024, driven by rising atrial fibrillation (AFib) & cardiovascular disease (CVD), supportive government policies and the technological advancements. This atrial fibrillation (AF) is very common, which is considered a risk factor for it has a lifetime incidence of approximately 1 in 3 to 5 people over the age of 45. AFib leads to significant hospitalization and death establish the urgent need for advanced cardiovascular emphasis devices each year. The market has grown with the increase in the prevalence of AFIB among older people in Canada. Important government initiatives supporting health promotion such as national research networks and provincial investments.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Cardiovascular Devices Market Size, Share, Growth Analysis, By Product (Diagnostic & Monitoring Devices, Surgical Devices), By Application (Coronary Artery Disease, Cardiac Arrhythmia), By End User (Hospitals, Specialty Clinics), By Region - Industry Forecast 2025-2032

Cardiovascular Devices Market Competitive Landscape

Cardiovascular Devices Market Report Snapshots

Want to customize this report?

FAQs

Request Free Customization

Feedback From Our Clients

$5,300

Cardiovascular Devices Market Size, Share, Growth Analysis, By Product (Diagnostic & Monitoring Devices, Surgical Devices), By Application (Coronary Artery Disease, Cardiac Arrhythmia), By End User (Hospitals, Specialty Clinics), By Region - Industry Forecast 2025-2032

Cardiovascular Devices Market Competitive Landscape

Cardiovascular Devices Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Cardiovascular Devices Market?

Who are the key vendors in the Cardiovascular Devices Market?

What is the key driver of Cardiovascular Devices Market?

What is the key market trend for Cardiovascular Devices Market?

Which region accounted for the largest share in Cardiovascular Devices Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300